[HTML][HTML] FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas

SF Barrington, R Kluge - European journal of nuclear medicine and …, 2017 - Springer
Abstract PET using 18 F-FDG for treatment monitoring in patients with lymphoma is one of
the most well-developed clinical applications. PET/CT is nowadays used during treatment to …

The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma

SF Barrington, J Trotman - The Lancet Haematology, 2021 - thelancet.com
This Review focuses on the use of 18 F-fluorodeoxyglucose (18 F-FDG) PET in the
assessment of diffuse large B-cell lymphoma, follicular lymphoma, and peripheral T-cell …

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

RO Casasnovas, R Bouabdallah, P Brice… - The lancet …, 2019 - thelancet.com
Background Increased-dose bleomycin, etoposide, doxorubicin, cyclophosphamide,
vincristine, procarbazine, and prednisone (BEACOPP escalated) improves progression-free …

[HTML][HTML] The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the …

A Gallamini, SF Barrington, A Biggi, S Chauvie… - …, 2014 - ncbi.nlm.nih.gov
A retrospective, international, multicenter study was undertaken to assess:(i) the prognostic
role of 'interim'positron emission tomography performed during treatment with doxorubicin …

An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax

E Itti, M Meignan, A Berriolo-Riedinger, A Biggi… - European journal of …, 2013 - Springer
Purpose The role of interim PET/CT in guiding therapeutic strategies in diffuse large B-cell
lymphoma (DLBCL) is debated, mainly because interpretation rules vary among centres …

SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma

RO Casasnovas, M Meignan… - Blood, The Journal …, 2011 - ashpublications.org
The prognostic value of interim positron emission tomography (PET) interpreted according to
visual criteria is a matter of debate in diffuse large B-cell lymphoma (DLBCL). Maximal …

FDG-PET–driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study

RO Casasnovas, L Ysebaert… - Blood, The Journal …, 2017 - ashpublications.org
Dose-dense induction and up-front consolidation with autologous stem cell transplantation
(ASCT) remain controversial issues when treating patients with high-risk diffuse large B-cell …

PET/CT in non-Hodgkin lymphoma: an update

L Zanoni, D Bezzi, C Nanni, A Paccagnella… - Seminars in Nuclear …, 2023 - Elsevier
Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative
disorders characterized by different clinical courses, varying from indolent to highly …

[HTML][HTML] Influence of software tool and methodological aspects of total metabolic tumor volume calculation on baseline [18F] FDG PET to predict survival in Hodgkin …

S Kanoun, I Tal, A Berriolo-Riedinger, C Rossi… - PloS one, 2015 - journals.plos.org
Aim To investigate the respective influence of software tool and total metabolic tumor volume
(TMTV0) calculation method on prognostic stratification of baseline 2-deoxy-2-[18F] fluoro-D …

Application of the Lugano classification for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the ProLog consensus …

F Ricard, B Cheson, S Barrington… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Our objective was to provide consensus recommendations from a consortium of academic
and industry experts in the field of lymphoma and imaging for consistent application of the …